FLIDINE MR (Trimetazidine (35mg))

Flidine MR 35mg Tablet is indicated for the management of angina pectoris, which is characterized by chest discomfort resulting from decreased blood supply to the heart. The medication assists in enhancing the heart’s efficiency in utilizing oxygen, thereby offering protection to heart cells during instances of diminished oxygen availability. This action may contribute to a decrease in both the frequency and intensity of angina episodes. For optimal therapeutic outcomes, it is essential to adhere strictly to your healthcare provider’s instructions regarding dosage, which is typically twice a day alongside meals. In addition to medication, embracing heart-healthy lifestyle changes, such as engaging in regular exercise, refraining from smoking, and maintaining a balanced diet low in fats, is strongly recommended. It is imperative not to miss any doses and to avoid discontinuing the medication without professional guidance, as doing so may lead to a resurgence of symptoms. While Flidine MR 35mg Tablet is effective for chronic angina management, it is not intended for the immediate relief of acute chest pain. Patients with Parkinson’s disease, severe kidney impairment, or movement disorders should not use this medication. If you experience dizziness or unsteadiness, it is advisable to avoid operating vehicles or machinery. Always communicate with your healthcare provider regarding any additional medications or pre-existing health conditions.